Indian Journal of Chemical Technology

Open Access Open Access  Restricted Access Subscription Access

Molecular Docking and Computational Studies Investigation on a Bioactive Anti-cancer Drug: Thiazole Derivatives


Affiliations
1 Department of Physics, Kongunadu College of Engineering & Technology, Thottiyam Tiruchirappalli 621 215, Tamil Nadu,, India
2 PG and Research Department of Physics, Srimad Andavan Arts and Science College, (Affiliated to Bharathidasan University) Tiruchirappalli 620 005, Tamil Nadu, India
3 Department of Physics, Arignar Anna Government Arts College, Musiri, (Affiliated to Bharathidasan University) Tiruchirappalli 621 211, Tamil Nadu,, India
 

In the present work, the 1-Benzyl-3-[2-(3-(4-chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1H-pyrazol-1-yl)-4-oxo-4,5-dihydro-1,3-thiazol-5(4H)-ylidene]-2,3-dihydro-1H-indol-2-one (BCPOT) anticancer candidates to treatment of breast cancer based on B3LYP level 6-31G(d,p) and LanL2DZ basis sets calculations and molecular docking. BCPOT have been proposed as potential stabilization energies, and topological properties have been evaluated as a function of acceptors and donor groups present in their structures. Detailed interpretation of the vibrational spectral assignments has been carried out using the Potential energy distribution (PED) analysis. The evaluation of the Fukui functions has also been carried out to describe the activity of the sites in the title compound. The non-covalent interaction (NCI) of the molecule has been explained by a reduced density gradient. Molecular electrostatic potential explains the nucleophilic and electrophilic reaction of the molecule. Molecular orbital interaction has been explained by Frontier molecular orbitals. For a better prediction of the anticancer properties of the proposed compound, molecular docking calculations are performed by using four structures of breast cancer activity. Docking results have been discussed based on binding affinities and the interaction types among ligands and different amino acid residues, indicating the powerful ability of ligands in front of the novel cancer disease.

Keywords

Thiazole, Anticancer, Molecular docking, Computational studies
User
Notifications
Font Size

  • Davide Romani & Silvia Antonia Brand, Int J Soc Res Methodol, 8 (2017) 66.

  • Ladetto María F, Arquez María J M, Romani Davide & Brand Silvia A, J Adv Chem, 16 (2019) 6325.

  • VijiA, Balachandran V, Babiyana S & Narayana B, J Mol Struc, 1203 (2020) 127452.

  • VijiA, Balachandran V, Babiyana S, Narayana B & Salian Vinutha V, J Mol Struc, 1215 (2020) 128244.

  • Salian Vinutha V, Narayana Badiadka, Sarojini Balladka K, Kumar Madan S, Nagananda Govinahalli S, Byrappa Kullaiah & Kudva Avinash K, Spectrochim Acta, 174 (2017) 254.

  • Frisch M J, Trucks G W, Schkegel H B, Scuseria G C, Robb M A, Cheeseman J R, Scalmani G, Barone V, Mennucci B, Bloino G A, Zheng G, Sonnenberg J L, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery J A, Peralta J E, Ogliaro F, Bearpark M, Heyd J J, Brothers E, Kudin K N, Staroverov V N, Keith T, Kobayashi R, Normand J, Rghavachri K, Rendell A, Burant J C, Iyengar S S, Tomasi J, Cossi M, Rega N, Millam J M, Klene M, Knox J E, Cross J B, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann R E, Yazyev O, Austin A J, Cammi R, Pomelli C, Ochterski J W, Martin R L, Morokuma K, Zakrzewski V G, Voth G A, Salvador P, Dannenberg J J,.Dapprich S, Daniels A D, Farkas O, Foresman J B, Ortiz J V, Cioslowski J, Fox D J, Gaussian Inc, Wallingford CT, Gaussian 09, Revision D.01, (2013).

  • Varghese H T, Panicker C Y & Philip D, J Raman Spect, 38 (2007) 309.

  • Lu T & Chen F, J Comput Chem, 33 (2012) 580.

  • Morris G M, Huey R, Lindstrom W, Sanner M F, Belew R K, Goodsell D S & Olson A J, J Comput Chem, 30 (2009) 2785.

  • Sheena Mary Y, Tresa Varghese Hema, Panicker C Y, Thiemann T, Al Saadi Saheeed Abdulaziz, Popoola A, Van Alsenoy C & Al Jasem Yosef, Spectrochim Acta A, 150 (2015) 533.

  • Erdogu Y, Tahir Gulluoolu M & Yurdakul S, J Mol Struct, 889 (2008) 361.

  • Ditchfield R, J Chem Phys, 56 (1972) 5688.

  • Hernandez O, Knight K S, Van Beek W, Boucekkine A, Boudjada A, Paulus W & Meinnel J, J Mol Struct, 791 (2006) 41.

  • Fatma S, Bishnoi A, Singh V, Al-Omary F A M, El-Emam A A, Pathak S, Srivastava R, Prasad O & Sinha L, J Mol Struct, 1110 (2016) 128.

  • Smith B, Infrared spectral interpretation, CRC Press, Boca Raton, (1999).

  • Durig J R, Little T S, Gounev T K, Gardner J K & Sullivan J F, J Mol Struct, 375 (1996) 83.

  • Kundoo S, Banarjee A N, Saha P & Chattopadhyaya K K, Mater Lett, 57 (2003) 2193.

  • Wattanathana W, Nootsuwan N, Veranitisagul C, Koonsaeng N, Suramitr S, Laobuthee A, Murugavel S, Sundaramoorthy S, Lakshmanan D, Subahashini R & Pavan Kumar P, J Mol Struct, 1131 (2017) 51.

  • Bellamy L J, Third Ed., Chapman and Halls, London, (1975).

  • Hiremath C S & Sundius T, Spectrochim Acta A, 74 (2009) 1260.

  • Silverstein R M, Webster F X & Kiemle D, Spectrometric identification of organic compounds, 2nd edn, (John-Wiley & Sons Inc. ), 2005.

  • Almutairi M S, Alanazi A M, Al-Abdullah E S, El-Emam A A, Pathak S K, Srivastava R, Prasad O & Sinha L, Spectrochim Acta A Mol Biomol Spectrosc, 140 (2015) 1.

  • Fliszar S, Charge Distributions and Chemical Effects, (Springer, New York), 1983.

  • Sponer J & Hobza P, Int J Quantum Chem, 57 (1996) 959.

  • Murry J S & Sen K, Molecular Electrostatic Potential Concepts and Applications, (Elsevier, Amesterdam), 1996.

  • Shoba D, Periandy S, Boomadevi S & Fereduni E, Spectrochim Acta A, 118 (2014) 438.

  • Edwin B, Amalanathan M & Hubert Joe I, Spectrochim Acta A, 96 (2012) 10.

  • Singh R N, Tiwari Kumar A, Rawat P, Baboo V & Divya Verma R K, Spectrochim Acta A, 92 (2012) 295.

  • Raveendran P R, Menon V V, Shyma M Y, Armakovic S, Armakovic S J & Panicker C Y, J Mol Struct, 1130 (2017) 208.

  • Morell C, Grand A & Toro-Labbe A, J Phys Chem A, 109 (2005) 205.

  • Aruldas D, Hubert Joe I, Roy S D D & Balachandran S, Spectrochim Acta A, 108 (2013) 89.

  • Johnson E R, Keinan S, Mori-Sanchez P, Contreras-Garcia J, Cohen A J & Yang W, J Am Chem Soc, 132 (2010) 6498.

  • Humphray W, Dalke A & Schulten K, J Mol Graph, 14 (1996) 33.

  • Silvi B & Savin A, Nature, 371 (1994) 683.

  • Jacobsen H, Can J Chem, 86 (2008) 695.

  • Becke A D & Edgecombe K E, J Chem Phys, 92 (1990) 5397.

  • Poater J, Duran M, Sola M & Silvi B, Chem Rev, 105 (2005) 3911. 38 RCSB protein data bank (http://www.rcsb.org/pdb/ home/home.do)

  • Viji A, Revathi B, Balachandran V, Babiyana S, Narayana B & Salian Vinutha V, Chem Data Collect, 30 (2020) 100585.


Abstract Views: 185

PDF Views: 140




  • Molecular Docking and Computational Studies Investigation on a Bioactive Anti-cancer Drug: Thiazole Derivatives

Abstract Views: 185  |  PDF Views: 140

Authors

A Viji
Department of Physics, Kongunadu College of Engineering & Technology, Thottiyam Tiruchirappalli 621 215, Tamil Nadu,, India
R Vijayakumar
PG and Research Department of Physics, Srimad Andavan Arts and Science College, (Affiliated to Bharathidasan University) Tiruchirappalli 620 005, Tamil Nadu, India
V Balachandran
Department of Physics, Arignar Anna Government Arts College, Musiri, (Affiliated to Bharathidasan University) Tiruchirappalli 621 211, Tamil Nadu,, India
K Vanasundari
Department of Physics, Arignar Anna Government Arts College, Musiri, (Affiliated to Bharathidasan University) Tiruchirappalli 621 211, Tamil Nadu,, India
M Janaki
Department of Physics, Kongunadu College of Engineering & Technology, Thottiyam Tiruchirappalli 621 215, Tamil Nadu,, India

Abstract


In the present work, the 1-Benzyl-3-[2-(3-(4-chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1H-pyrazol-1-yl)-4-oxo-4,5-dihydro-1,3-thiazol-5(4H)-ylidene]-2,3-dihydro-1H-indol-2-one (BCPOT) anticancer candidates to treatment of breast cancer based on B3LYP level 6-31G(d,p) and LanL2DZ basis sets calculations and molecular docking. BCPOT have been proposed as potential stabilization energies, and topological properties have been evaluated as a function of acceptors and donor groups present in their structures. Detailed interpretation of the vibrational spectral assignments has been carried out using the Potential energy distribution (PED) analysis. The evaluation of the Fukui functions has also been carried out to describe the activity of the sites in the title compound. The non-covalent interaction (NCI) of the molecule has been explained by a reduced density gradient. Molecular electrostatic potential explains the nucleophilic and electrophilic reaction of the molecule. Molecular orbital interaction has been explained by Frontier molecular orbitals. For a better prediction of the anticancer properties of the proposed compound, molecular docking calculations are performed by using four structures of breast cancer activity. Docking results have been discussed based on binding affinities and the interaction types among ligands and different amino acid residues, indicating the powerful ability of ligands in front of the novel cancer disease.

Keywords


Thiazole, Anticancer, Molecular docking, Computational studies

References